Chemotherapy-induced immunosuppression and reconstitution of immune function (Q77626145)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11839388%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

title

Chemotherapy-induced immunosuppression and reconstitution of immune function (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11839388%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

1 reference

Timothy A Steele

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11839388%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

publication date

1 April 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11839388%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11839388%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

volume

26

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11839388%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11839388%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

page(s)

411-414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11839388%20AND%20SRC:MED&resulttype=core&format=json

Enhancement of leukemia rejection by mice successfully treated for L1210 leukemia due to low dose compared to high dose VP-16.

7 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

T-cell immunodeficiency following cytotoxic antineoplastic therapy: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

Quantitative Relationships Between Circulating Leukocytes and Infection in Patients with Acute Leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

Immune reconstitution after autologous purged bone marrow transplantation in children

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

Reconstitution of peripheral blood lymphocyte subsets in the long-term disease-free survivors of patients with acute myeloblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

T cells and natural killer cells after treatment of hairy cell leukaemia with 2-chlorodeoxyadenosine.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

Recovery of natural killer cells after chemotherapy for childhood acute lymphoblastic leukemia and solid tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

Host defense, viruses and apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

Natural killer cells and cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

Immune recovery in children with malignancy after cessation of chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

CD4+ T-lymphocytopenia in long-term survivors following intensive chemotherapy in childhood cancers

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

Attempted reconstruction of the immune system using low doses of interleukin 2 in chronic lymphocytic leukemia patients treated with 2-chlorodeoxyadenosine: results of a pilot study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

T-cell regeneration: all repertoires are not created equal

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

Cytokine responsiveness of mitogen-activated T cells derived from acute leukemia patients with chemotherapy-induced leukopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

Cellular immune responses in acute leukaemia patients with severe chemotherapy-induced leucopenia; characterization of the cytokine repertoire of clonogenic T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

Different interleukin-1 beta converting enzyme (ICE) family protease requirements for the apoptotic death of T lymphocytes triggered by diverse stimuli

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

Adverse side-effects associated with G-CSF in patients with chronic myeloid leukemia undergoing allogeneic peripheral blood stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

Pilot trial of interleukin-2 with granulocyte colony-stimulating factor for the mobilization of progenitor cells in advanced breast cancer patients undergoing high-dose chemotherapy: expansion of immune effectors within the stem-cell graft and post-s

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

A potential role for interleukin-7 in T-cell homeostasis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

Antileukemic effect of chronic graft-versus-host disease: contribution to improved survival after allogeneic marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

Adoptive allogeneic immunotherapy--history and future perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

The role of disease stage in the response to donor lymphocyte infusions as treatment for leukemic relapse

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

Donor leukocyte transfusions for leukemic relapse.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900138-2

7 January 2021

10.1016/S0145-2126(01)00138-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11839388%20AND%20SRC:MED&resulttype=core&format=json

7 December 2019

1 reference